Search company, investor...


Founded Year



Asset Sale | AssetsPurchased

Total Raised


About Europroteome

Developer of early diagnostic and prognostic tools, patient-specific therapeutics, and immune therapy for human epithelial cancers. The company applies convergent gene expression technologies, in particular proteomics and transcriptomics to human epithelial cancers (e.g. colon or lung cancer) in order to identify cancer-specific protein expression patterns (targets or markers) suited for clinical applications. After characterizing and validating these identified targets, the company offers these targets for co-development agreements with industrial clients and marketing partners.

Headquarters Location

Neuendorfstrasse 24a

Hennigsdorf, 16761,


49 33 0220232 50

Missing: Europroteome's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Europroteome's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Europroteome Frequently Asked Questions (FAQ)

  • When was Europroteome founded?

    Europroteome was founded in 1998.

  • Where is Europroteome's headquarters?

    Europroteome's headquarters is located at Neuendorfstrasse 24a, Hennigsdorf.

  • What is Europroteome's latest funding round?

    Europroteome's latest funding round is Asset Sale.

  • How much did Europroteome raise?

    Europroteome raised a total of $15.07M.

  • Who are the investors of Europroteome?

    Investors of Europroteome include Genmab, Heidelberg Innovation, Earlybird Venture Capital, Nextech Invest, Aventic Partners and 4 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.